Sign Up for FORCE
Newsletters
IMPROVING THE LIVES OF INDIVIDUALS AND FAMILIES FACING HEREDITARY CANCER.
November 01, 2022
Lynch Syndrome, an ATM Mutation and Issues of Gender Identity and Fertility Access
by Scarlett Shiloh (they/them) Unfortunately, You Have Lynch Syndrome and an ATM Mutation I remember exactly how I felt hearing my genetic counselor say the word “unfortunately.” On March 10, 2022, I found out I inherited Lynch syndrome (I...
Featured XRAY
Screening for pancreatic cancer detects early-stage disease and improves survival
A research study has shown that screening for pancreatic cancer in people with an inherited mutation or family history was able to detect early-stage pancreatic cancers and improve survival. These results will likely change pancreatic...
Featured Research
PARP inhibitor (niraparib) in patients with inherited or tumor PALB2 mutations in advanced solid tumors (PAVO)
PAVO is an open-label Phase II study investigating if the study drug, a PARP inhibitor called niraparib (Zejula), is safe and effective for certain people who have been diagnosed with an advanced solid tumor with...
Meet Our Community
Our impact is best shared through the stories of our growing community. Read about the survivors and previvors facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers as a result of a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those with Lynch syndrome. We are comprised of many mutations and many cancers but we are one community!
